ExodusPoint Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

ExodusPoint Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-62,666	Closed	-$1.52M	–	2356
2023 Q1	$1.52M	Buy	+62,666	New	+$1.37M	0.01%	994
2022 Q4	–	Sell	-128,324	Closed	-$2.3M	–	2286
2022 Q3	$2.3M	Buy	128,324 +7,376	+6%	+$96.8K	0.03%	739
2022 Q2	$1.16M	Sell	120,948 -495	-0.4%	-$6.21K	0.01%	1009
2022 Q1	$2.04M	Buy	+121,443	New	+$1.79M	0.03%	769
2021 Q3	–	Sell	-12,226	Closed	-$77K	–	2823
2021 Q2	$77K	Buy	+12,226	New	+$78.9K	﹤0.01%	2186
2021 Q1	–	Sell	-65,373	Closed	-$452K	–	2743
2020 Q4	$452K	Buy	+65,373	New	+$418K	﹤0.01%	1318
2020 Q2	–	Sell	-104,111	Closed	-$358K	–	2103
2020 Q1	$358K	Buy	104,111 +64,037	+160%	+$374K	0.02%	601
2019 Q4	$344K	Buy	+40,074	New	+$143K	0.01%	1074

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

ExodusPoint Capital Management's ISEE Position: Q2 2023 in Review

ExodusPoint Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 62,666 shares — an estimated $1.52M sold.

ExodusPoint Capital Management first reported a position in ISEE in Q4 2019 and held it in 8 quarters. The position peaked at $2.3M in Q3 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

ExodusPoint Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 62,666 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $1.52M.
ExodusPoint Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
ExodusPoint Capital Management's IVERIC bio, Inc. Common Stock position peaked at $2.3M in Q3 2022.
256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.